HIV incidence in eastern and southern Africa has historically been concentrated among girls
and women aged 15-24 years. As new cases decline with HIV interventions, population …

Daily oral tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) as HIV pre-exposure
prophylaxis (PrEP) is a safe and effective method for HIV prevention and offers potential to …

Background: The dapivirine vaginal ring (“the ring”) reduced HIV acquisition by about 35%
in phase III trials, with modeling from open-label extension trials estimating 50% HIV …

Compelling evidence regarding the HIV/AIDS reduction potentials of male circumcision
abounds in sub-Saharan Africa, but men aged 15 to 59 years in Nigeria are mostly …

Background: The global burden of intimate partner violence (IPV) and sexually transmitted
infections (STIs) remains substantial. South Africa, the setting for this study, is …

The development of an effective vaccine against HIV-1 is thought to be a key component of
combating the current HIV epidemic. This study aimed to investigate viral reservoirs in the …

Globally, the human immunodeficiency virus (HIV) epidemic is currently in its fourth decade.
In sub-Saharan Africa (sSA), the HIV epidemic was initially considered to be largely a result …

A coordinated system of disease surveillance will be critical to effectively control the
coronavirus disease 2019 (Covid-19) pandemic. Such systems enable rapid detection and …

Background: The combination of poverty, HIV and depression in the perinatal period
represents a major public health challenge in many Southern African countries. In some …

Abstract Introduction: Pre-exposure prophylaxis (PrEP) has the potential to alter the HIV
epidemic in South Africa. Between 2016 and 2018 PrEP was rolled-out for 18-24 year-old …